Micro Labs Limited — Diclofenac Exporter Profile
Indian Pharmaceutical Exporter · #8 for Diclofenac · $8.8M export value · DGFT Verified
Micro Labs Limited is the #8 Indian exporter of Diclofenac with $8.8M in export value and 177 verified shipments. Micro Labs Limited holds a 2.4% market share in Diclofenac exports across 18 countries. The company exports 76 pharmaceutical products worth $463.6M across 21 therapeutic categories.
Micro Labs Limited — Diclofenac Export Profile: Buyers & Destinations
Where Does Micro Labs Limited Export Diclofenac?
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALTA | $1.9M | 40 | 19.1% |
| FRANCE | $1.8M | 37 | 17.6% |
| GERMANY | $1.5M | 67 | 15.1% |
| CANADA | $1.4M | 30 | 14.4% |
| NETHERLANDS | $813.1K | 25 | 8.1% |
| BELGIUM | $737.7K | 29 | 7.4% |
| UNITED STATES | $437.9K | 9 | 4.4% |
| SRI LANKA | $320.9K | 26 | 3.2% |
| IRAQ | $234.5K | 18 | 2.3% |
| TURKEY | $203.7K | 14 | 2.0% |
Micro Labs Limited exports Diclofenac to 21 countries. The largest destination is MALTA accounting for 19.1% of Micro Labs Limited's Diclofenac shipments, followed by FRANCE (17.6%) and GERMANY (15.1%). These destinations reflect Micro Labs Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Diclofenac from Micro Labs Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| CENTRE SPECIALITES PHARMACEUTIQUES | FRANCE | $1.8M | 37 |
| MICRO LABS GMBH | BELGIUM | $1.6M | 52 |
| PHARMADOX HEALTHCARE LTD | MALTA | $1.1M | 22 |
| DORVAL | CANADA | $1.1M | 22 |
| MSK PHARMALOGISTIC GMBH | GERMANY | $608.2K | 25 |
| MSK PHARMALOGISTIC GMBH. | GERMANY | $574.8K | 31 |
| PHARMADOX HEALTHCARE LIMITED | MALTA | $480.4K | 11 |
| PHARMADOX HEALTHCARE LTD, | MALTA | $350.0K | 7 |
| EVERSANA LIFE SCIENCE SERVICES, LLC | UNITED STATES | $295.6K | 6 |
| AL-KAWKAB SCIENTIFIC BUREAU | JORDAN | $251.2K | 19 |
Micro Labs Limited supplies Diclofenac to 42 buyers globally. The largest buyer is CENTRE SPECIALITES PHARMACEUTIQUES (FRANCE), followed by MICRO LABS GMBH (BELGIUM) and PHARMADOX HEALTHCARE LTD (MALTA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Diclofenac Export Value and How Much Does Micro Labs Limited Contribute?
India exported $119.5M worth of Diclofenac through 15,000 shipments from 1007 suppliers to 173 countries, serving 2,731 buyers globally. Micro Labs Limited contributes $8.8M to this total, accounting for 2.4% of India's Diclofenac exports. Micro Labs Limited ships Diclofenac to 21 countries through 42 buyers.
What Is the Average Shipment Value for Micro Labs Limited's Diclofenac Exports?
Micro Labs Limited's average Diclofenac shipment value is $50.0K per consignment, based on 177 shipments totaling $8.8M. The largest destination is MALTA (19.1% of Micro Labs Limited's Diclofenac exports).
How Does Micro Labs Limited Compare to Other Indian Diclofenac Exporters?
Micro Labs Limited ranks #8 among 1007 Indian Diclofenac exporters with a 2.4% market share. The top 3 exporters are CIPLA LIMITED ($20.9M), TROIKAA PHARMACEUTICALS LIMITED ($16.0M), CAPLIN POINT LABORATORIES LIMITED ($15.5M). Micro Labs Limited processed 177 shipments to 18 destination countries.
What Diclofenac Formulations Does Micro Labs Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| DICLOFENAC-NATRIUM MICRO LABS 75 MG RETA | $436.6K | 14 |
| DICLOFENAC BIOGARAN L.P.75MG(DICLOFENAC | $350.0K | 7 |
| DICLOFENAC NATRIUM MICRO LABS 75MG RETAR | $319.6K | 12 |
| DICLOFENAC VIATRIS L.P. 75MG ( DICLOFEN | $200.0K | 4 |
| DICLOFENAC-NATRIUM MICRO LABS 75MG RETAR | $194.1K | 7 |
| DICLOFENAC BIOGARAN L.P.75MGDICLOFENACSODIUM 75MG PROLONGED REL.FILM COATED TABS3x10'STAX DOCUMENT NO:706204824/31.08.23 | $150.0K | 3 |
| DICLOFENAC BIOGARAN L.P.75MGDICLOFENACSODIUM 75MG PROLONGED REL.FILM COATED TABS3x10'STAX DOCUMENT NO:706204820/30.08.23 | $150.0K | 3 |
| DICLOFENAC VIATRIS L.P.75 MG(DICLOFENACSODIUM 75MG PROLONGED-RELEASE FILM-COATED TABLETS) PACK 3 X10`S,QTY-258401.000PCS | $150.0K | 3 |
| DICLOFENAC VIATRIS L.P 75MG (DICLOFENACSODIUM 75MG PROLONGED RELEASE FILM COATED TABLETS,PACK 3X10`S,QTY 192797.000PCS | $150.0K | 3 |
| DICLOFENAC VIATRIS L.P 75MG (DICLOFENACSODIUM 75MG PROLONGED RELEASE FILM-COATED TABLETS,PACK 3X10,QTY 223806.000 | $150.0K | 3 |
Micro Labs Limited exports 212 distinct Diclofenac formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DICLOFENAC-NATRIUM MICRO LABS 75 MG RETA with 14 shipments worth $436.6K.
Regulatory Requirements: Exporting Diclofenac to Key Markets
What Micro Labs Limited must comply with to export Diclofenac to its top destination countries
Germany — BfArM/EMA
Approval Process
Marketing Authorisation via Decentralized or Mutual Recognition Procedure under EU Directive 2001/83/EC. CTD Module 1–5 dossier required.
Timeline: 12–18 months via Decentralized Procedure
GMP & Export Requirements
EU GMP (EudraLex Vol. 4); GMP certificate from EU competent authority; WHO Prequalification accepted as supporting evidence
Certificate of Pharmaceutical Product (CPP) from CDSCO; Written Confirmation for API export per EU requirements; EU FMD serialization mandatory
Note: Indian manufacturers must hold EU GMP certificate. EU Falsified Medicines Directive (FMD) serialization and tamper-evident packaging mandatory.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Micro Labs Limited Compare to Nearest Diclofenac Exporters?
Exporters ranked immediately above and below #8 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 7 | ENCUBE ETHICALS PRIVATE LIMITED | $10.1M | 201 | 2 | $50.0K |
| 1 | LINCOLN PHARMACEUTICALS LTD | $8.9M | 179 | 22 | $50.0K |
| 8 | MICRO LABS LIMITED ★ | $8.8M | 177 | 18 | $50.0K |
| 9 | DR.REDDY'S LABORATORIES LTD | $8.3M | 165 | 1 | $50.0K |
| 13 | DR REDDYS LABORATORIES LIMITED | $4.9M | 98 | 1 | $50.0K |
Micro Labs Limited ranks #8 among 1007 Indian Diclofenac exporters. Average shipment value of $50.0K compared to the market average of $118.7K. The closest competitors by value are ENCUBE ETHICALS PRIVATE LIMITED and LINCOLN PHARMACEUTICALS LTD.
Which Indian Ports Ship Diclofenac Exports?
| Port | Shipments | % Share |
|---|---|---|
| NHAVA SHEVA SEA (INNSA1) | 2,481 | 16.5% |
| JNPT/ NHAVA SHEVA SEA | 1,272 | 8.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 1,186 | 7.9% |
| SAHAR AIR | 903 | 6.0% |
| JNPT | 712 | 4.7% |
| DELHI AIR CARGO ACC (INDEL4) | 679 | 4.5% |
| NHAVA SHEVA | 676 | 4.5% |
| Bombay Air | 491 | 3.3% |
What Other Analgesics & Antipyretics Products Does Micro Labs Limited Export?
Micro Labs Limited also exports these analgesics & antipyretics products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Micro Labs Limited's Diclofenac Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Micro Labs Limited. The Israel-Iran conflict has intensified tensions in the Red Sea, leading to increased shipping costs and potential delays. These disruptions can affect supply chain efficiency and profitability, necessitating strategic adjustments in logistics and distribution channels.
Conversely, the U.S.-China trade tensions have prompted the United States to diversify its pharmaceutical supply sources, creating an opportunity for Indian exporters to capture a larger market share. Micro Labs can leverage this shift by emphasizing its compliance with U.S. regulatory standards and ensuring a reliable supply chain.
The recent India-European Union Free Trade Agreement, signed in January 2026, is poised to eliminate tariffs on most European pharmaceutical exports to India. While this enhances market access for European manufacturers, it also intensifies competition for Indian exporters. Micro Labs must enhance its value proposition through innovation, cost efficiency, and adherence to EU regulatory standards to maintain its competitive edge. (en.wikipedia.org)
Micro Labs Limited — Regulatory Compliance & Quality Standards
Compliance with international regulatory standards is paramount for pharmaceutical exporters. Micro Labs Limited has demonstrated a commitment to quality, as evidenced by its recognition as India’s Most Technically and Scientifically Advanced Pharmaceutical Manufacturing Company in 2024. This accolade reflects the company's adherence to stringent manufacturing practices and international guidelines. (einnews.com)
However, the evolving regulatory landscape, including the EU's Falsified Medicines Directive and the U.S. FDA's stringent quality requirements, necessitates continuous investment in compliance infrastructure. Micro Labs must proactively adapt to these changes to ensure uninterrupted market access and maintain its reputation for quality.
About Micro Labs Limited
Micro Labs Limited exports 76 products worth $463.6M. Beyond Diclofenac, top products include Amoxicillin, Potassium, Gabapentin, Losartan, Esomeprazole. View the complete Micro Labs Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Diclofenac — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Diclofenac shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Micro Labs Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 342 individual customs records matching Micro Labs Limited exporting Diclofenac, covering 212 formulations to 21 countries via 42 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 173+ countries, 2,731+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Diclofenac Export Data from Micro Labs Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Micro Labs Limited's Diclofenac exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Micro Labs Limited
Full Company Profile →
76 products · $463.6M total trade · 21 categories
Diclofenac Stats
Company Overview
Top Products by Micro Labs Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Micro Labs Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Diclofenac. For current shipment-level data, contact TransData Nexus.